A detailed history of Los Angeles Capital Management LLC transactions in Revolution Medicines, Inc. stock. As of the latest transaction made, Los Angeles Capital Management LLC holds 7,228 shares of RVMD stock, worth $312,900. This represents 0.0% of its overall portfolio holdings.

Number of Shares
7,228
Previous 7,451 2.99%
Holding current value
$312,900
Previous $289,000 13.15%
% of portfolio
0.0%
Previous 0.0%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 04, 2024

SELL
$36.92 - $47.94 $8,233 - $10,690
-223 Reduced 2.99%
7,228 $327,000
Q2 2024

Aug 05, 2024

SELL
$30.14 - $40.68 $47,229 - $63,745
-1,567 Reduced 17.38%
7,451 $289,000
Q1 2024

Apr 05, 2024

BUY
$26.56 - $33.55 $5,763 - $7,280
217 Added 2.47%
9,018 $290,000
Q4 2023

Feb 06, 2024

BUY
$18.35 - $34.12 $161,498 - $300,290
8,801 New
8,801 $252,000
Q2 2023

Aug 03, 2023

BUY
$20.28 - $27.0 $235,531 - $313,578
11,614 New
11,614 $310,000

Others Institutions Holding RVMD

About Revolution Medicines, Inc.


  • Ticker RVMD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 87,697,600
  • Market Cap $3.8B
  • Description
  • Revolution Medicines, Inc., a clinical-stage precision oncology company, focuses on developing therapies to inhibit frontier targets in RAS-addicted cancers. The company is developing RMC-4630, an inhibitor of SHP2, which is in Phase 1/2 clinical trial for the treatment of solid tumors, such as gynecologic and colorectal cancer tumors. It also d...
More about RVMD
Track This Portfolio

Track Los Angeles Capital Management LLC Portfolio

Follow Los Angeles Capital Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Los Angeles Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Los Angeles Capital Management LLC with notifications on news.